Core Viewpoint - A class action has been filed against Mynaric AG due to allegations of misleading investors regarding its business prospects, particularly concerning production delays and financial guidance for FY 2024 [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that Mynaric failed to disclose production delays caused by lower-than-expected production yields and component supplier shortages, which negatively impacted revenue growth and led to an operating loss [2]. - Mynaric revised its FY 2024 revenue guidance from a range of EUR 50.0 million to EUR 70.0 million down to EUR 16.0 million to EUR 24.0 million, and its operating loss guidance from a range of EUR 30.0 million to EUR 40.0 million up to a loss of EUR 50.0 million to EUR 55.0 million [3]. - Following the announcement of these issues, Mynaric's American Depository Share price fell by $2.32, or 55.9%, closing at $1.83 on August 20, 2024 [4]. Group 2: Legal Proceedings - Shareholders who wish to serve as lead plaintiffs in the class action must submit their applications by December 30, 2024, although participation is not required to be eligible for recovery [5]. - Robbins LLP, the law firm handling the case, operates on a contingency fee basis, meaning shareholders incur no fees or expenses [6].
MYNA Shareholders with Significant Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Mynaric AG Class Action